OSE_1212_part2_Layout 1 12/5/12 9:53 AM Page 123
S T A M P I N G
O U T
S S I
S
The CDC hasn't endorsed the effectiveness of coated catheters,
although it suggests that facilities unable to lower their CAUTI
rate through other interventions might consider their use.
Additionally, in a study in the Nov. 2, 2012, issue of the journal
Lancet, British researchers saw no significant difference in results
following their short-term use. "Silver alloy-coated catheters were
not effective for reduction of incidence of symptomatic CAUTI,"
the authors wrote, "The reduction we noted in CAUTI associated
with nitrofural-impregnated catheters was less than that regarded
as clinically important. Routine use of antimicrobial-impregnated
catheters is not supported by this trial."
Then there's the question of cost. A pricier coated catheter may
be preferable to treating UTI (which Medicare hasn't reimbursed
since 2008), says Dr. Manasse. But in the quick and cost-conscious outpatient OR, is it worth it?
Cost isn't the only concern about coated catheters, though. "One
always has to be concerned about exposing organisms to antibiotics, for fear of fostering resistance to a drug, or creating a multidrug resistant organism," says Dr. Manasse. He suggests the use
of condom catheters among male patients, which offer a noninvasive alternative, although not one that can resolve retention.
Removal and reinforcement
Catheter removal, the guidelines agree, should be done as soon as
D E C E M B E R 2012 | O U T PAT I E N T S U R G E R Y M A G A Z I N E O N L I N E
1 2 3
